Ethinyl Estradiol; Norelgestromin Patent Expiration
Ethinyl Estradiol; Norelgestromin is Used for preventing ovulation in women. It was first introduced by Janssen Pharmaceuticals Inc
Ethinyl Estradiol; Norelgestromin Patents
Given below is the list of patents protecting Ethinyl Estradiol; Norelgestromin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ortho Evra | US5876746 | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
Nov 20, 2015
(Expired) | Janssen Pharms |
| Ortho Evra | US5972377 | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
Jun 07, 2015
(Expired) | Janssen Pharms |
Ethinyl Estradiol; Norelgestromin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List